Patent intelligence · US
US 6013679
Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
Patent details — US 6013679
- Jurisdiction
- US
- Status
- expired
- Grant date
- Jan 11, 2000
- Expiration
- Jan 6, 2020
- Applicant
- Anika Research, Inc.
- Claims
- 19
- CPC classes
- A61K, A61K47/36, A61K47/61, A61K47/6903
Quick answer
US 6013679 (Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use) is held by Anika Research, Inc.. Status: expired. Granted Jan 11, 2000. Expires Jan 6, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Anika Research, Inc.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K47/36, A61K47/61, A61K47/6903, A61K9/0014, A61K9/0019
More from Anika Research, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12415779
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof
granted -
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted -
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12077506
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
granted -
US 11939303
Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, their medical use and the method of obtaining 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamate derivatives
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted
Frequently asked questions
What is US patent 6013679?
US 6013679 (Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use) is held by Anika Research, Inc.. Status: expired. Granted Jan 11, 2000. Expires Jan 6, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6013679?
Anika Research, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 69 pharmaceutical patents for this assignee.
When does US 6013679 expire?
Our index shows an expiration date of Jan 6, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.